Thus, decreasing intracellular GSH renders tumor cells more susceptible to oxidative stress and chemotherapeutic drugs (9)
Anderson SL, Beutel TR, Trujillo JM
10.3920/BM2021.0151 22 DashD.MishraV.PandaM
The discrepancy may be attributed to the distinct metabolic characteristics of cells and the variations in the induction approaches used in different studies 18,23
Benefits of GLP-1 (Glucagon-like peptide 1) receptor agonists for stroke reduction in type 2 diabetes: A call to action for neurologists
Roughly 31% of survey participants who reported using insulin also reported using GLP-1 drugs, as did about 28% of patients who were using oral drugs to control their blood sugar, according to the report, indicating that these treatments are being integrated into combination regimens